Mpox patients' experience from infection to treatment and implications for prevention and control : A multicenter qualitative study in China
© 2023 Wiley Periodicals LLC..
Monkeypox (mpox), a viral zoonotic disease, is spreading worldwide. However, evidence that informs prevention and control strategies in the Asia Pacific Region is very limited. Our study aims to investigate the experiences of mpox patients from infection to treatment to provide scientific basis for the prevention and control. A multicenter qualitative design was used. A total of 15 mpox patients were recruited between July 6 and July 25, 2023, from six cities in China. Semistructured interviews were conducted by telephone and analyzed using the thematic analysis. The interview was divided into two sections: patients' experiences (prediagnosis experience, treatment-seeking experience, and quarantine experience) and advice. Prediagnosis experience was summarized into three themes: symptoms, possible routes of infection, and knowledge of mpox. Treatment-seeking experience was summarized into three themes: time of visit to hospital, diagnostic difficulties, and attitude toward diagnosis. Quarantine experience was summarized into three themes: body and mind reactions, reluctance to self-disclose infection status, and factors facilitating recovery. Themes identified from patients' advice were as follows: (1) Increase in testing channels and methods, (2) Development and introduction of vaccines, (3) Adjustment of quarantine program, (4) Improvement of treatment measures, and (5) Improvement of publicity and education. To effectively curb the mpox epidemic, structured measures are urgently needed to address the mpox-related stigma and discrimination. Targeted health education should be provided to MSM, focusing on the prevention, detection, and treatment services. Hospitals should enhance the training of clinicians in key departments including infectious disease and dermatology, to improve diagnostic capability and sensitivity. Furthermore, given the absence of specific antiviral medications, supervised home quarantine may be a good option.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
Journal of medical virology - 96(2024), 1 vom: 13. Jan., Seite e29338 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Weijie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiviral Agents |
|---|
| Anmerkungen: |
Date Completed 03.01.2024 Date Revised 14.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/jmv.29338 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366539191 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366539191 | ||
| 003 | DE-627 | ||
| 005 | 20240214233042.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jmv.29338 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1293.xml |
| 035 | |a (DE-627)NLM366539191 | ||
| 035 | |a (NLM)38163280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Weijie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mpox patients' experience from infection to treatment and implications for prevention and control |b A multicenter qualitative study in China |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2024 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Wiley Periodicals LLC. | ||
| 520 | |a Monkeypox (mpox), a viral zoonotic disease, is spreading worldwide. However, evidence that informs prevention and control strategies in the Asia Pacific Region is very limited. Our study aims to investigate the experiences of mpox patients from infection to treatment to provide scientific basis for the prevention and control. A multicenter qualitative design was used. A total of 15 mpox patients were recruited between July 6 and July 25, 2023, from six cities in China. Semistructured interviews were conducted by telephone and analyzed using the thematic analysis. The interview was divided into two sections: patients' experiences (prediagnosis experience, treatment-seeking experience, and quarantine experience) and advice. Prediagnosis experience was summarized into three themes: symptoms, possible routes of infection, and knowledge of mpox. Treatment-seeking experience was summarized into three themes: time of visit to hospital, diagnostic difficulties, and attitude toward diagnosis. Quarantine experience was summarized into three themes: body and mind reactions, reluctance to self-disclose infection status, and factors facilitating recovery. Themes identified from patients' advice were as follows: (1) Increase in testing channels and methods, (2) Development and introduction of vaccines, (3) Adjustment of quarantine program, (4) Improvement of treatment measures, and (5) Improvement of publicity and education. To effectively curb the mpox epidemic, structured measures are urgently needed to address the mpox-related stigma and discrimination. Targeted health education should be provided to MSM, focusing on the prevention, detection, and treatment services. Hospitals should enhance the training of clinicians in key departments including infectious disease and dermatology, to improve diagnostic capability and sensitivity. Furthermore, given the absence of specific antiviral medications, supervised home quarantine may be a good option | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a China | |
| 650 | 4 | |a mpox | |
| 650 | 4 | |a patient's experience | |
| 650 | 4 | |a qualitative study | |
| 650 | 4 | |a quarantine | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Qi, Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Liuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Meng, Xiaojun |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Guangyong |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Sitong |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Jiapeng |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Bingyi |e verfasserin |4 aut | |
| 700 | 1 | |a Fu, Leiwen |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Baihui |e verfasserin |4 aut | |
| 700 | 1 | |a He, Jinbo |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ye |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Fuxiang |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Yuanlong |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Wanxian |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Siyang |e verfasserin |4 aut | |
| 700 | 1 | |a He, Longtao |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Lv, Fan |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Hongzhou |e verfasserin |4 aut | |
| 700 | 1 | |a Qian, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Zou, Huachun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 96(2024), 1 vom: 13. Jan., Seite e29338 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2024 |g number:1 |g day:13 |g month:01 |g pages:e29338 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.29338 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2024 |e 1 |b 13 |c 01 |h e29338 | ||